Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime

Substance Abuse

Volumn 33, Issue 1, 2012, Pages 30-39

  Gryczynski, Jan ^a   Kinlock, Timothy W ^a   Kelly, Sharon M ^a   Ogrady, Kevin E ^b   Gordon, Michael S ^a   Schwartz, Robert P ^a  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Legal pressure; methadone; motivation; opioid agonist maintenance; probationers

Indexed keywords

ACETYLMETHADOL; METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CRIME; DRUG POTENTIATION; FEMALE; HEROIN DEPENDENCE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; OPIATE ADDICTION; PATIENT COMPLIANCE; PRISONER; PROPORTIONAL HAZARDS MODEL; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANALGESICS, OPIOID; BALTIMORE; CRIME; FEMALE; HEROIN DEPENDENCE; HUMANS; LONGITUDINAL STUDIES; MALE; METHADONE; METHADYL ACETATE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; PRISONERS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856913212     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2011.616816     Document Type: Article

References (35)

1. Mauer M, King R. A 25-year quagmire: the war on drugs and its impact on American society; 2007. Available at: http://www.sentencingproject.org/Admin/ Documents/publications/dp 25yearquagmire.pdf. Accessed December 1, 2007.
2. Mumola C, Karberg J. Drug Use and Dependence, State and Federal Prisoners, 2004. Washington, DC: US Department of Justice; 2006. Bureau of Justice Statistics Special Report (NCJ 213530).
3. Maruschak L. HIV in Prisons, 2007-2008. Washington, DC: US Department of Justice, Office of Justice Programs; 2009. Bureau of Justice Statistics Bulletin (NCJ 228307).
4. Hammett T, Harmon M, Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities. Am J Public Health. 2002;92:189-194.
5. Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiatemaintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005;28:321-329.
6. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction. 1998;93:515-532.
7. Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O'Grady KE. A randomized clinical trial ofmethadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat. 2009;37:277-285.
8. Garcia C, Correa G, Hernandez Viver A, et al. Buprenorphine-naloxone treatment for pre-release opioiddependent inmates in Puerto Rico. J Addict Med. 2007;1:126-132.
9. Magura S, Lee JD, Hershberger J, et al. Buprenorphine and methadone maintenance in jail and postrelease: a randomized clinical trial. Drug Alcohol Depend. 2009;99:222-230.
10. Stallwitz A, Stover H. The impact of substitution treatment in prisons-a literature review. Int J Drug Policy. 2007;18:464-474.
11. World Health Organization. Effectiveness of Interventions to Manage HIV in Prisons-Opioid Substitution Therapies and OtherDrug Dependence Treatment. Geneva: United Nations Office of Drugs and Crime, United Nations Programme on HIV/AIDS; 2007.
12. Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301:183-190.
13. Fiscella K, Moore A, Engerman J, Meldrum S.Management of opiate detoxification in jails. J Addict Dis. 2005;24:61-71.
14. Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD.Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105:83-88.
15. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set, 2007. Washington, DC: US Department of Health and Human Services; 2007.
16. Glaze L, Bonczar T. Probation and Parole in the United States, 2008. Washington, DC: US Department of Justice, Office of Justice Programs; 2009. Bureau of Justice Statistics Bulletin (NCJ 228230).
17. McMillan G, Lapham S. Staff perspectives on methadone maintenance therapy (MMT) in a large southwestern jail. Addict Res Theory. 2005;13:53-63.
18. Sung H-E, Belenko S, Feng L, Tabachnick C. Predicting treatment noncompliance among criminal justicemandated clients: a theoretical and empirical investigation. J Subst Abuse Treat. 2004;26:13-26.
19. Joe GW, Simpson DD, Broome KM. Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend. 1999;57:113-125.
20. Booth R, Corsi K, Mikulich-Gilbertson S. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 2003;74:177-185.
21. Simpson D, Joe G. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993;30:357-368.
22. Gryczynski J, Schwartz R, O'Grady K, Jaffe J. Dropout from interim methadone and subsequent comprehensive methadone maintenance. Am J Drug Alcohol Abuse. 2009;35:394-398.
23. Kelly J, Finney J, Moos R. Substance use disorder patients who are mandated to treatment: characteristics, treatment process, and 1- and 5-year outcomes. J Subst Abuse Treat. 2005;28:213-223.
24. Polcin D. Drug and alcohol offenders coerced into treatment: a review of modalities and suggestions for research on social model programs. Subst Use Misuse. 2001;36:589-608.
25. Desmond DP, Maddux JF. Compulsory supervision and methadone maintenance. J Subst Abuse Treat. 1996;13:79-83.
26. Anglin M, Brecht M-L, Maddahian E. Pretreatment characteristics and treatment performance of legally coerced versus voluntary methadone maintenance admissions. Criminology. 1989;27:537-558.
27. Joseph H. A probation department treats heroin addicts. Federal Probation. 1973;37:35-39.
28. CzuchryM, Sia T, Dansereau D. Improving early engagement and treatment readiness of probationers: gender differences. Prison J. 2006;86:56-74.
29. McLellan A, Cacciola J, Alterman A, Rikoon S, Carise D. The Addiction Severity Index at 25: origins, contributions, and transitions. Am J Addict. 2006;15:113-124.
30. Knight K, Holcom M, Simpson D. TCU psychosocial functioning and motivation scales: manual on psychometric properties; 1994. Available at: http://www.ibr.tcu.edu/pubs/datacoll/kk6-srf-95.pdf. Accessed March 12, 2010.
31. Sobell M, Sobell M. The Timeline Followback: A Calendar Method for Assessing Alcohol and Drug Use. Toronto, Canada: Addiction Research Foundation; 1996.
32. Anglin M. The efficacy of civil commitment in treating narcotic addiction. In: Leukefeld C, Tims F, eds. Compulsory Treatment of Drug Abuse: Research and Clinical Practice.Rockville,MD: National Institute on Drug Abuse; 1988:8-34.
33. Hanlon T, Nurco D, Bateman R, O'Grady K. The response of drug abuser parolees to a combination of treatment and intensive supervision. Prison J. 1998;78:31-44.
34. Simpson D, JoeG,BrownB.Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997;11:294-307.
35. Kelly S, Schwartz R, O'Grady K, et al. Gender differences among in- and out-of-treatment opioid-addicted individuals. Am J Drug Alcohol Abuse. 2009;35:38-42.